Selsun

Quick links to important sections

Selsun

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Selsun

Property Description
Active ingredient Selenium Sulfide
Form Suspension (typically a specialized shampoo)
Pharmacological class Cytostatic and Antifungal agent
Common use Management of scaling and flaking skin conditions
Origin Synthetic compound

Selsun: Definition, Type, and Pharmacological Class

Selsun is a topical drug whose medicinal identity is characterized by a dual pharmacological class, making it both a cytostatic agent and an antifungal agent. This specific formulation, widely used in dermatological practice, is intended strictly for application to the skin surface. As a well-established product on the market, it is typically available as an Over-the-Counter (OTC) preparation, distinguishing it from higher-strength pharmaceutical solutions that may require a prescription.


What is the Active Ingredient in Selsun and its Delivery Form?

The sole active ingredient in Selsun is Selenium Sulfide (SeS2), a synthetic compound that dictates the drug's therapeutic function. Selenium Sulfide is utilized for its ability to reduce cell turnover and manage certain fungal conditions on the skin, a function central to its role in dermatology. This means the medicine is documented to help slow down the overgrowth of skin cells while fighting related microbial issues.

The active entity is delivered as an aqueous suspension, which is most frequently presented as a specialized shampoo to facilitate topical application to the scalp and other hair-bearing skin areas. This formulation is designed for its role in controlling visible flaking.


What is the General Therapeutic Purpose of Selsun?

The general therapeutic purpose of Selsun is to achieve simultaneous symptomatic relief by controlling two key contributors to specific superficial dermatological conditions. Its mechanism focuses on limiting the excessive turnover and shedding of skin cells while simultaneously restricting the growth of relevant surface fungi. This combined approach is a foundational strategy for managing persistent scaling, flaking, and irritation caused by these intertwined physiological and microbial processes.

Regulatory References

  1. MedlinePlus Drug Information on Selenium Sulfide
  2. DailyMed Label for Selenium Sulfide 2.5% Lotion

What side effects are possible with Selsun?

Possible Side Effects and Safety Information

The safety profile for topical Selenium Sulfide is primarily characterized by effects concerning the Skin and Subcutaneous Tissue and Hair and Follicle Disorders. Many of the local reactions, such as skin irritation at the application site, dryness or oiliness of the scalp, and diffuse, transient hair loss, are listed in regulatory documents with a Frequency Not Known classification.

Frequency-Classified and Systemic Risks

Some adverse reactions, including Hypersensitivity and Urticaria (Hives), are officially classified as Rare in official prescribing information. The regulatory labeling highlights the potential for serious adverse reactions linked to misuse. Specifically, the risk of Systemic Toxicity is documented if the product is applied to broken, severely inflamed, or exudating skin due to increased absorption. Accidental contact with the eye can result in serious localized injury, including Corneal abrasion.

Population and Exposure Constraints

The use of this medication is not recommended for children under 5 years of age, as specified in regulatory documents. Furthermore, the official safety documentation notes that local effects like blistering may occur if the product is left in contact with the skin for longer than the recommended duration. For individuals who are pregnant or breastfeeding, the label states no adverse effects are anticipated, but the product must not be used on the breast area during lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for this product is structured around two primary exposure risks: accidental ingestion and excessive systemic absorption.

Documented Overdose Exposures

Overdose Pathway Potential Clinical Manifestations
Accidental Oral Ingestion The primary acute risk. May lead to gastrointestinal symptoms such as nausea and vomiting. Animal studies suggest that the ingestion of large amounts carries the potential for human toxicity.
Topical Over-exposure Overuse, or application to broken, acutely inflamed, or oozing areas of skin, can lead to increased systemic absorption. Symptoms of systemic toxicity may include tremors, weakness, lethargy, loss of appetite, severe perspiration, and a garlicky odor of the breath.

Emergency Action Required

Immediate medical advice must be sought in the event of accidental ingestion of the shampoo, regardless of the amount. Contact a Poison Control Center or emergency room at once. General supportive measures are required in the event of toxicity. Patients must also seek medical advice if they develop signs of systemic toxicity following topical use, particularly when applied to areas of compromised skin which may increase absorption.

Therapeutic Uses of Selsun

What Selsun Treats: Main Uses and Benefits

The medication is commonly used to address conditions involving certain distressing symptoms on the scalp and body. In clinical application, Selsun may assist with easing the itching and flaking associated with dandruff and seborrheic dermatitis of the scalp. This product is relevant for managing conditions characterized by symptoms of persistent scaling, pruritus (itching), greasiness, and the skin discoloration linked to Tinea Versicolor.

Symptomatic Relief and Clinical Contexts

Selsun is primarily applied across therapeutic domains where additional symptomatic support is needed, particularly for managing recurrent and persistent issues. It is utilized as an adjunctive treatment in specific scalp fungal conditions to manage associated scaling. For many patients, the medication may assist with easing the overall symptom load:

“The treatment may help patients cope more steadily with symptom fluctuations during episodes of heightened discomfort.”


Quick Fact

Quick Fact: Relief for Flaking and Pruritus
Common Use Contexts: Managing symptoms of dandruff, seborrheic dermatitis, and Tinea Versicolor (Pityriasis Versicolor).
Patient Benefit: Supports general well-being during symptomatic periods and is relevant for easing the overall symptom load associated with recurrent issues.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Selsun — Official Regulatory Information

The official eligibility profile for the topical formulation of Selenium Sulfide (Selsun) is defined by mandatory exclusions and limitations established in regulatory labeling. The product is contraindicated in specific populations and under certain physical conditions, as documented by authorities.


Populations Contraindicated (Must Not Use)

  • Hypersensitivity: Individuals with a known or suspected hypersensitivity to Selenium Sulfide or any other ingredient in the formulation.
  • Compromised Skin: Patients with broken skin, acutely inflamed areas, or sites with exudation (oozing) at the application site. This restriction is based on the risk of increased systemic absorption and potential toxicity.

Population-Specific Limitations and Restrictions

  • Pediatric Use: Safety and effectiveness have not been established in children under 12 years of age for the prescription-strength product.
  • Pregnancy Status: Use is not recommended for pregnant women under ordinary circumstances (FDA Pregnancy Category C). Use must be determined only if the potential benefit justifies the potential risk.
  • Lactation: Caution is required when the product is administered to a nursing woman, as it is not known if the drug is secreted into human milk following topical application.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory labeling establishes that Selenium Sulfide topical suspension has no known significant systemic drug-drug interactions. This finding is due to the medicine's topical route of administration and minimal systemic absorption when applied to intact skin.

Documented Interaction Restrictions

The interaction profile is primarily defined by mandatory administration restrictions and conditions that alter exposure risk, as formalized in government prescribing information.

Restriction Type Regulatory Statement
Systemic Exposure Risk Application to broken or acutely inflamed skin may increase systemic absorption, heightening the risk of internal exposure.
Topical Co-Administration Simultaneous use of other topical medications on the treatment area must be avoided to prevent potential alteration of effectiveness or absorption.
Timing Requirements The medicine must not be applied for a period of two days before or after chemical hair treatments (e.g., dyeing, permanent waves) to mitigate the risk of hair discoloration.

Interactions with Food, Alcohol, and Supplements

Official documents state there are no known interactions with food or drinks. The interaction with alcohol is formally classified as unknown or not reported in regulatory information. No specific interactions with herbal products or supplements are formally documented in official interaction tables.

Mechanism of Action

Selenium sulfide, the active pharmaceutical ingredient in Selsun, exerts its action through two primary biological mechanisms: cytostatic activity and antifungal properties. The compound accumulates topically on the epidermal and follicular epithelium of the scalp. ****

Its cytostatic mechanism involves inhibiting the proliferation of keratinocytes. Specifically, selenium sulfide decreases the rate of cellular turnover within the epidermal layer by interfering with mitotic activity. This action reduces the formation of new corneocytes and subsequent shedding.

Concurrently, selenium sulfide possesses antifungal properties by targeting and inhibiting the growth of Malassezia species, such as M. globosa and M. furfur, which are integral components of the scalp's microbial environment. This fungistatic effect is mediated by the compound's interference with the cellular metabolism of the yeast, potentially involving the generation of intracellular reactive oxygen species (ROS), which disrupts fungal cell integrity and viability.

The combined antimitotic and fungistatic actions modulate the physiological processes of the scalp's cellular and microbial populations.

Dosage and Administration Information

The administration of selenium sulfide topical suspension is strictly limited to external use, applied directly to the affected skin area or scalp as a liquid suspension. The product is available in varying strengths, including 1% (often non-prescription) and 2.5% (often prescription-only). Before application, the container must be shaken well.


Dosing Regimens and Frequency

The standard usage pattern varies depending on the clinical context. For the management of common scaling conditions on the scalp, the typical dose is approximately 5 to 10 milliliters (one to two teaspoonsful) of the suspension. This initial therapy is typically administered twice weekly. Once initial control is achieved, the frequency is reduced to a maintenance regimen, applied intermittently as needed, ranging from weekly, every two weeks, or every three to four weeks. In contrast, the application for treating Tinea Versicolor involves applying the suspension once daily for a fixed course of seven consecutive days.


Application Technique and Procedural Constraints

Proper use involves specific contact times and post-application steps. For the scalp, the lather must remain on the surface for two to three minutes before being thoroughly rinsed and the process is typically repeated. When used on the body, the product must remain on the skin for ten minutes before rinsing. After use, hands must be washed well. A special procedural constraint notes that all jewelry should be removed prior to use to prevent damage, and light-colored or chemically treated hair requires an extended five-minute rinse with cool water to mitigate the potential for discoloration. Furthermore, the safety and effectiveness of this preparation are not established in infants.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Selsun (Selenium Sulfide)

This section provides a descriptive overview of the types of research and clinical trials that have examined topical Selenium Sulfide (Selsun). The information is presented to describe the structure of the evidence and what was measured, without offering clinical advice or treatment recommendations. Research provides context but not individual predictions, and study results reflect the specific conditions under which they were conducted.


Evidence for Use in Dandruff (Pityriasis Simplex Capitis)

Research for dandruff was studied primarily through short-term, randomized controlled trials (RCTs). Researchers monitored outcomes related to physical discomfort, specifically by measuring changes in scaling scores and assessing patient-reported outcomes describing perceived discomfort, such as itching. Studies observed measured outcomes in the group using the active ingredient that differed from those in the control group. However, many primary efficacy trials had follow-up durations that were limited, meaning there is limited information for characterizing how consistent these changes are over many months.


Evidence for Use in Seborrheic Dermatitis of the Scalp (SSD)

For seborrheic dermatitis, evidence was derived from randomized comparative trials and observational cohorts. These studies explored the product's use in adults and focused on outcomes linked to inflammatory or irritative states using validated severity scales. The evidence shows patterns where reported measurements in severity scores differed across study formulations and trial settings. Comparative evidence is lacking for a full assessment across all available concentrations (e.g., 1% versus 2.5%).


Evidence for Use in Tinea Versicolor (Pityriasis Versicolor)

The evidence base for Tinea Versicolor is largely sourced from double-blind, randomized controlled trials (RCTs). Research focused on two main endpoints: mycological clearance (a lab test confirming the absence of fungus) and the clinical resolution of visible skin lesions. Trials reported the rate of mycological clearance following short-term application schedules. The time required for full normalization of skin color following reported fungal clearance is not precisely measured in a consistent manner across the existing literature.


Long-Term Study Durations and Evidence Gaps

Clinical research was typically designed to observe responses over defined time intervals, such as 4 to 8 weeks. Follow-up durations were limited in many primary trials. Consequently, data for certain groups remain insufficient for use in children under the age of 12 for most indications, as they are not consistently included in high-level efficacy trials.

Key Studies & References

  1. A randomized, controlled clinical trial of four anti-dandruff shampoos
  2. Label: SELENIUM SULFIDE shampoo - DailyMed (Regulatory document for indication and usage statements)

Frequently Asked Questions (FAQ)

Common questions about Selsun (FAQ)


Q: What is the difference between Selsun and Selsun Blue?

Regulatory documents indicate that Selsun (selenium sulfide) is available in different product lines, including prescription and over-the-counter (OTC) strengths. The main difference often relates to the concentration of the active ingredient (e.g., 2.5% versus 1%) and the specific inactive ingredients used in the product’s formulation.


Q: Is it normal to experience a strong smell after using Selsun?

Official monographs describe the selenium sulfide ingredient itself as having a faint odor. However, most commercial formulations include fragrances as inactive ingredients that contribute to the product's smell. In rare cases associated with systemic exposure (e.g., misuse), a distinct odor has been documented.


Q: What conditions, besides dandruff, is Selsun sometimes used for?

According to official product information, Selsun is indicated for the treatment of seborrheic dermatitis of the scalp and for the fungal skin infection known as Tinea Versicolor. The product is indicated for addressing the flaking, scaling, and inflammation associated with these conditions.


Q: Are there any long-term risks associated with using Selsun regularly?

Clinical trial data has often focused on short-term use, meaning information regarding very long-term risks is limited in official documents. However, official regulatory warnings highlight the risk of systemic exposure if the product is applied to broken skin or used for prolonged periods.


Q: Can children or teenagers use Selsun?

Official labeling states that the safety and effectiveness of this medicine have not been established in infants. Use is generally not recommended for children younger than 2 years of age. For children ge 2 years, specific dosage instructions are described in the official product information for the available strengths.


Q: What should I do if I accidentally get Selsun in my eyes?

Official safety warnings state that accidental contact with the eyes can cause severe localized injury. If this occurs, the product label describes the required procedure as rinsing the eyes thoroughly with water for several minutes.


Q: Are there common side effects that people report when starting Selsun?

The most frequently reported local effects include skin irritation, oiliness or dryness of the scalp/hair, hair loss, and hair discoloration. It is important to note that many of these local effects are listed with a 'Frequency Not Known' classification in official prescribing information.


Q: What is the standard duration of use described in official information for Selsun?

For the treatment of Tinea Versicolor, the standard duration described in official information is typically once daily for seven days. For dandruff and seborrheic dermatitis, official labeling suggests two applications each week for two weeks will usually provide control, followed by use at less frequent, intermittent intervals as needed.


Q: If I stop using Selsun, will the condition come back immediately?

The official regimen requires initial treatment followed by intermittent use to maintain relief. As is common with topical treatments for chronic conditions, if treatment is stopped, the underlying condition may return, and continued maintenance use may be required.


Q: Can I use Selsun if I have a sensitive scalp or existing skin issues?

Official precautions state that the product should not be used on broken skin or when acute inflammation or oozing is present on the skin or scalp, as this may increase absorption. Application may also cause skin irritation or sensitization; if this occurs, regulatory advice describes that use should be discontinued.


Q: Can Selsun be used on facial hair or eyebrows?

For the treatment of Tinea Versicolor, official guidance states to apply to the affected areas of the body except for your face and genitals. For scalp conditions, application is generally focused on the scalp itself, and specific guidance for facial hair or eyebrows is absent from official documents.


Q: Why is it described that Selsun should not be swallowed?

The product is for external use only and is not intended to be ingested. Although serious toxicity from accidental ingestion is rare in humans, the active ingredient could result in potential human toxicity if swallowed in large amounts, according to official warnings and animal studies.


Q: Does Selsun contain sulfates or parabens?

Official labeling (DailyMed) for some formulations lists ingredients such as Ammonium Lauryl Sulfate and sometimes Methylparaben and Propylparaben as inactive ingredients. The specific formulation used may differ, requiring users to check the inactive ingredients list on their product packaging.


Q: Is there a maximum amount of time official sources describe for continuous use?

Official information for seborrheic conditions does not specify a maximum time for continuous use. The guidelines note that the maintenance regimen should be used at less frequent intervals (e.g., weekly, every 2-4 weeks) and not more frequently than required to maintain control.


Q: Are there any special instructions for people with fine or thin hair when using Selsun?

Official directions do not specifically address hair structure like 'fine or thin' hair texture. However, the regulatory label requires that light-colored or chemically treated hair must be rinsed well for at least 5 minutes to help prevent discoloration.


Q: Is Selsun considered a treatment for oily scalp?

Official indications list its use for dandruff and seborrheic dermatitis, but do not list oily scalp as a condition it is intended to treat alone. Regulatory monographs note that changes to the scalp, such as increased oiliness or dryness, may occur as an adverse reaction to the product.


Q: Are there specific instructions for rinsing out the product that people often miss?

Official directions emphasize the need to rinse thoroughly to minimize potential side effects. A specific, extended rinse of at least 5 minutes with cool water is required for light-colored or chemically treated hair to help mitigate the risk of discoloration.


Q: What should I do if I notice skin irritation after using Selsun?

Official warnings state that if skin irritation or sensitization occurs, regulatory documents describe that use of the product is to be discontinued. Regulatory advice suggests that patients be aware of the need to contact their healthcare provider if the condition worsens or if a rash develops.

How should Selsun be stored and disposed of?

How to Store and Dispose of Selsun?

Selsun (Selenium Sulfide Topical Suspension) must be stored strictly according to regulatory mandates to maintain its stability.


Storage Requirements

The product requires storage at Controlled Room Temperature, defined as 20°C to 25°C (68°F to 77°F), with permitted excursions up to 30°C. It is mandatory to protect the suspension from freezing and excessive heat and to keep the container tightly closed to prevent environmental degradation. Like all medicines, Selsun must be stored out of the sight and reach of children.


Disposal Instructions

Official disposal guidance states that unused or expired product must be discarded in accordance with local and federal regulations. Due to the environmental toxicity of the active ingredient, the suspension must not be allowed to enter drains, sewers, or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Selsun found in:

A-Z Index: